Related Articles
Mitochondrial ultrastructure-associated chemotherapy response in ovarian cancer
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer
TBX2 expression is associated with platinum‑sensitivity of ovarian serous carcinoma
Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series
Role of Fyn expression in predicting the sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma